24th International Workshop on Long-term Complications of HIV and SARS-CoV-2

项目摘要 随着抗逆转录病毒疗法（ART）的成功，合并症现在是主要原因 地球仪各地艾滋病毒感染者的死亡和残疾率，包括中低收入国家和地区 收入国家（LMIC）。大型会议是科学交流的重要场所， 艾滋病研究的最新进展，但更小，更亲密的格式， 强调讨论和建立网络对艾滋病毒感染者的职业发展至关重要 investigators.此外，需要建立一个论坛，就急性期后 COVID-19（PASC）的后遗症，这是一种知之甚少的综合征，可能与其他疾病的致病性 艾滋病合并症的特征。我们的研讨会，现在在其第24个年头，并更名为国际 艾滋病毒和SARS-CoV-2长期并发症研讨会，提供<200名国际 代表们有机会聚在一起讨论最新的调查结果和争议， 艾滋病毒科摩罗和PASC研究在一个房间，两天的格式。全体发言人是 来自艾滋病毒研究之外的知名专家或在特定领域具有专业知识的艾滋病毒研究人员 科摩罗。一个高度互动的PASC圆桌会议，有2-3个小型会谈，突出了关键和 PASC的发病机制和管理中出现的问题。摘要介绍 包括26个15分钟的演讲和海报会议，为研究人员提供了充足的机会， 展示并获得他们最新工作的反馈。有了这个R13，我们建议加强第24次 讲习班（11月5日/6日，纽约市），目的如下：1）为下列方面提供一个论坛： 通过向LMIC调查人员提供旅行奖学金， 支持LMIC中国际公认的非传染性疾病专家， 全体会议发言人，并与国际培训计划联络，2）提供持续和 扩大论坛，讨论和传播有关PASC的最新研究成果， 3)通过奖学金计划支持早期艾滋病患者和PASC研究人员 职业发展工作室。通过为艾滋病毒感染者和PASC提供一个“科学之家”， 通过来自世界各地的研究人员，我们希望促进未来艾滋病毒的研究工作， 合并症和PASC，并促进将研究结果转化为临床策略 可以延长艾滋病毒携带者和长期COVID患者的寿命和健康寿命。

Project Summary With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including in low and middle income countries (LMIC). Large meetings are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. In addition, there is a need for a forum for scientific exchange regarding post-acute sequelae of COVID-19 (PASC), a poorly understood syndrome which may share pathogenic features with HIV comorbidities. Our workshop, now in its 24th year and renamed the International Workshop on Long-term Complications of HIV and SARS-CoV-2, provides <200 international delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity and PASC research in a one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. A highly interactive PASC roundtable, with 2-3 mini-talks, highlights critical and emerging issues in the pathogenesis and management of PASC. Abstract presentations including 26 15-minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 24th Workshop (November 5th/6th in New York City) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to provide a continued and expanded forum for discussion and dissemination of the latest research findings regarding PASC, 3) to support early-stage HIV Comorbidity and PASC investigators with a scholarship program and a Career Development Studio. By providing a “scientific home” to HIV Comorbidity and PASC investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and PASC and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH and those with long COVID.